AI assistant
Thyrocare Technologies Limited Call Transcript 2021
61766_rns_2021-02-03_90677328-b496-4695-a8b2-32914434cbc5.pdf
Call Transcript
Open in viewerOpens in your device viewer
February 03, 2021
To,
National Stock Exchange of India Limited Exchange Plaza Bandra Kurla Complex, Bandra (E), Mumbai - 400 05 I
BSE Limited Phiroze Jeejeeboy Towers Dalal Street, Mumbai- 400 00 I
I
Dear Sir/Madam,
Sub: Disclosure of information under Regulation 30 of SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015.
--0--
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that a conference call for the Indian and overseas analysts is arranged by our management to discuss the Company's financial results for Quarter / Nine Months ended December 31, 2020, on Thursday, February 04, 2021 at 05.00 P.M. local time.
Dr. A. Yelumani, Chairman & Managing Director, Mr. Arindam Haldar, Chief Executive Officer, Mr. A. Sundararaju, Executive Director & CFO and Mr. Sachin Salvi, Vice-President- Finance, will represent the Company. Dial-in details are given in the copy of enclosed Invite ofM/s. Nomura Financial Advisory & Securities (rndia) Pvt. Ltd., who are organizing the con-call.
Yours Faithfully,
For Thyrocare Technologies Limited,
Ramjee Dorai Company Secretary and Compliance Officer
Thyrocare Technologies Limited
**9**D-37/1, TTC MIDC, Turbhe, Navi Mumbai - 400 703, India (9 022- 3090 0000 / 4125 2525 I 11?:.i [email protected] (i www.thyrocare.com
Thyrocare Technologies LTD. (THYROCAR IN) Q3 FY21 Earnings call
Nomura is pleased to invite you to Thyrocare Technologies Limited (THYROCAR IN) Post Earnings Conference call. This format offers Fund Managers/Buy-side analysts an opportunity to interact with Thyrocare top management to discuss the company's recent performance, current state of operations and business strategy going ahead.
We look forward to your participation in this event.
Express Join with DiamondPass™ No Wait Time
https://services.choruscall.in/DiamondPassRegistration/register? confirmationNumber=7742307&linkSecurityString=18bdc732b7
OR
Use below dial ins
(PIN number is not required, you will be accessed by an operator to capture your Name & Company)
| Country | Toll Free | Toll |
|---|---|---|
| India | +91-7045671221 | +91 22 6280 1548 |
| (all over India) | +91 22 7115 8376 | |
| (Universal Dial In) | ||
| Hong Kong | 800964448 | +852 30186877 |
| Singapore | 8001012045 | +65 31575746 |
| United Kingdom | 08081011573 | +44 2034785524 |
| United States | 18667462133 | +1 3233868721 |
Day & Date:
Thursday, February 4, 2021
Time:
05:00pm-06:00pm IST | 06:30am – 07:30am EST | 11:30am – 12:30pm UK | 03:30Pm-04:30am UAE | 07:30pm-08:30pm HKT/SGT
Company Delegates:
Dr. A Velumani, Ph.D – Chairman and Managing Director Mr. Arindam Haldar – CEO Mr. A Sundararaju – CFO and Executive Director Mr. Sachin Salvi – Vice President, Finance
Company Description:
Thyrocare is one of the country's leading diagnostic laboratories promoting the use of preventive diagnostic tests. With the use of advanced instrumentation, automation systems and IT infrastructure, Thyrocare delivers one of the fastest and most accurate test results.
Moderator:
Prateek Mandhana – Associate, Equity Research (India Healthcare) T: +91 8291397533 E: [email protected]
Nomura Sales Contact:
Abhimanyu Kalra E: [email protected]
This event is being organized by Nomura for its clients for their general information and education. Nomura has not independently verified the information that you may receive from a third party presenter ("Presenter") during the event and takes no responsibility for that information that is provided or for any use by the clients of that information at any time thereafter. Any views and opinions given are those of the relevant Presenter and not those of Nomura. www.nomura.com